Farmers & Merchants Investments Inc. Has $182,000 Holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Farmers & Merchants Investments Inc. reduced its position in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 19.4% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 20,367 shares of the pharmacy operator’s stock after selling 4,907 shares during the period. Farmers & Merchants Investments Inc.’s holdings in Walgreens Boots Alliance were worth $182,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds have also added to or reduced their stakes in WBA. Scientech Research LLC bought a new position in Walgreens Boots Alliance during the second quarter worth $1,215,000. Ariel Investments LLC grew its position in shares of Walgreens Boots Alliance by 10.8% during the 2nd quarter. Ariel Investments LLC now owns 2,038,878 shares of the pharmacy operator’s stock worth $24,660,000 after buying an additional 198,891 shares during the period. Exchange Traded Concepts LLC acquired a new position in shares of Walgreens Boots Alliance during the 3rd quarter valued at $795,000. Clifford Capital Partners LLC grew its holdings in Walgreens Boots Alliance by 58.4% in the second quarter. Clifford Capital Partners LLC now owns 803,204 shares of the pharmacy operator’s stock worth $9,715,000 after purchasing an additional 296,135 shares during the period. Finally, Cetera Investment Advisers boosted its position in shares of Walgreens Boots Alliance by 89.8% during the 1st quarter. Cetera Investment Advisers now owns 349,464 shares of the pharmacy operator’s stock worth $7,580,000 after purchasing an additional 165,389 shares in the last quarter. 58.59% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several analysts recently issued reports on WBA shares. Evercore ISI lifted their price target on shares of Walgreens Boots Alliance from $7.50 to $10.00 and gave the company an “in-line” rating in a research report on Wednesday, October 16th. JPMorgan Chase & Co. reduced their price objective on shares of Walgreens Boots Alliance from $20.00 to $15.00 and set an “overweight” rating for the company in a research report on Friday, August 30th. Royal Bank of Canada dropped their target price on Walgreens Boots Alliance from $22.00 to $13.00 and set a “sector perform” rating on the stock in a research report on Tuesday, July 2nd. TD Cowen lowered their price target on shares of Walgreens Boots Alliance from $16.00 to $14.00 and set a “buy” rating on the stock in a report on Tuesday, October 22nd. Finally, Bank of America reduced their price target on shares of Walgreens Boots Alliance from $11.00 to $7.50 and set an “underperform” rating for the company in a research report on Wednesday, September 4th. Four investment analysts have rated the stock with a sell rating, nine have assigned a hold rating and two have issued a buy rating to the stock. According to MarketBeat.com, Walgreens Boots Alliance presently has an average rating of “Hold” and a consensus target price of $12.88.

Walgreens Boots Alliance Trading Down 1.0 %

NASDAQ:WBA opened at $9.35 on Wednesday. The company has a debt-to-equity ratio of 0.67, a current ratio of 0.68 and a quick ratio of 0.37. The firm has a market capitalization of $8.08 billion, a P/E ratio of -0.93, a PEG ratio of 1.20 and a beta of 0.70. The company’s 50-day simple moving average is $9.26 and its 200 day simple moving average is $12.61. Walgreens Boots Alliance, Inc. has a one year low of $8.22 and a one year high of $27.05.

Walgreens Boots Alliance (NASDAQ:WBA) last posted its quarterly earnings results on Tuesday, October 15th. The pharmacy operator reported $0.39 EPS for the quarter, beating analysts’ consensus estimates of $0.36 by $0.03. Walgreens Boots Alliance had a negative net margin of 5.85% and a positive return on equity of 14.23%. The firm had revenue of $37.50 billion for the quarter, compared to analysts’ expectations of $35.75 billion. During the same quarter in the prior year, the company posted $0.67 earnings per share. The business’s revenue for the quarter was up 5.9% on a year-over-year basis. As a group, analysts forecast that Walgreens Boots Alliance, Inc. will post 1.54 EPS for the current fiscal year.

Walgreens Boots Alliance Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, December 12th. Stockholders of record on Monday, November 18th will be issued a dividend of $0.25 per share. The ex-dividend date is Monday, November 18th. This represents a $1.00 annualized dividend and a dividend yield of 10.70%. Walgreens Boots Alliance’s payout ratio is -9.99%.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.